Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013 (2013), Article ID 821650, 6 pages
http://dx.doi.org/10.1155/2013/821650
Review Article

Treatment of Periprosthetic Infections: An Economic Analysis

1Hospital St Agustín and School of Medicine, 33400 Oviedo, Spain
2Orthopaedic Surgery and Traumatology Institute, 08009 Barcelona, Spain
3Hospital of Cartagena, 30203 Murcia, Spain
4Hospital of Cabueñes and School of Medicine, 33394 Oviedo, Spain
5Hospital Costa del Sol, 29603 Marbella, Spain
6Hospital Sabogal, Colina 1081, Bellavista-Callao, Peru

Received 26 February 2013; Accepted 30 April 2013

Academic Editors: S.-Y. Kim, W. Klauser, M. S. Lee, and C. S. Mow

Copyright © 2013 Daniel Hernández-Vaquero et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. J. Bozic, S. M. Kurtz, E. Lau, K. Ong, D. T. P. Vail, and D. J. Berry, “The epidemiology of revision total hip arthroplasty in the united states,” Journal of Bone and Joint Surgery A, vol. 91, no. 1, pp. 128–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. J. Bozic, S. M. Kurtz, E. Lau et al., “The epidemiology of revision total knee arthroplasty in the united states,” Clinical Orthopaedics and Related Research, vol. 468, no. 1, pp. 45–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. E. R. Bohm, M. J. Dunbar, J. J. Frood, T. M. Johnson, and K. A. Morris, “Rehospitalizations, early revisions, infections, and hospital resource use in the first year after hip and knee arthroplasties,” Journal of Arthroplasty, vol. 27, no. 2, pp. 232–237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Kurtz, K. L. Ong, J. Schmier et al., “Future clinical and economic impact of revision total hip and knee arthroplasty,” Journal of Bone and Joint Surgery A, vol. 89, supplement 3, pp. 144–151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Brauer and K. J. Bozic, “Using observational data for decision analysis and economic analysis,” Journal of Bone and Joint Surgery A, vol. 91, supplement 3, pp. 73–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. A. Brauer, A. B. Rosen, N. V. Olchanski, and P. J. Neumann, “Cost-utility analyses in orthopaedic surgery,” Journal of Bone and Joint Surgery A, vol. 87, no. 6, pp. 1253–1259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. W. R. Burns, R. B. Bourne, B. M. Chesworth, S. J. MacDonald, and C. H. Rorabeck, “Cost effectiveness of revision total knee arthroplasty,” Clinical Orthopaedics and Related Research, vol. 446, pp. 29–33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Laupacis, R. Bourne, C. Rorabeck et al., “The effect of elective total hip replacement on health-related quality of life,” Journal of Bone and Joint Surgery A, vol. 75, no. 11, pp. 1619–1626, 1993. View at Google Scholar · View at Scopus
  9. A. D. Beswick, K. T. Elvers, A. J. Smith, R. Gooberman-Hill, A. Lovering, and A. W. Blom, “What is the evidence base to guide surgical treatment of infected hip prostheses? Systematic review of longitudinal studies in unselected patients,” BMC Medicine, vol. 10, article 18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. L. Cahill, B. Shadbolt, J. M. Scarvell, and P. N. Smith, “Quality of life after infection in total joint replacement,” Journal of Orthopaedic Surgery, vol. 16, no. 1, pp. 58–65, 2008. View at Google Scholar · View at Scopus
  11. C. S. Bryan, S. L. Morgan, R. J. Caton, and E. M. Lunceford, “Cefazolin versus cefamandole for prophylaxis during total joint arthroplasty,” Clinical Orthopaedics and Related Research, vol. 228, pp. 117–122, 1988. View at Google Scholar · View at Scopus
  12. A. Glenny and F. Song, “Antimicrobial prophylaxis in total hip replacement: a systematic review,” Health Technology Assessment, vol. 3, no. 21, pp. 1–57, 1999. View at Google Scholar · View at Scopus
  13. J. S. Heydemann and C. L. Nelson, “Short-term preventive antibiotics,” Clinical Orthopaedics and Related Research, vol. 205, pp. 184–187, 1986. View at Google Scholar · View at Scopus
  14. B. AlBuhairn, D. Hind, and A. Hutchinson, “Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review,” Journal of Bone and Joint Surgery B, vol. 90, no. 7, pp. 915–919, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. L. B. Engesæter, S. A. Lie, B. Espehaug, O. Furnes, S. E. Vollset, and L. I. Havelin, “Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0–14 years in the Norwegian Arthroplasty Register,” Acta Orthopaedica Scandinavica, vol. 74, no. 6, pp. 644–651, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. S. Cummins, I. M. Tomek, S. R. Kantor, O. Furnes, L. B. Engesæter, and S. R. G. Finlayson, “Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty,” Journal of Bone and Joint Surgery A, vol. 91, no. 3, pp. 634–641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Slover, J. P. Haas, M. Quirno, M. S. Phillips, and J. A. Bosco, “Cost-effectiveness of a Staphylococcus aureus screening and decolonization program for high-risk orthopaedic patients,” Journal of Arthroplasty, vol. 26, no. 3, pp. 360–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. T. N. Peel, M. M. Dowsey, K. L. Buising, D. Liew, and P. F. M. Choong, “Cost analysis of debridement and retention for management of prosthetic joint infection,” Clinical Microbiology and Infection, vol. 19, no. 2, pp. 181–186, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. D. N. Fisman, D. T. Reilly, A. W. Karchmer, and S. J. Goldie, “Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly,” Clinical Infectious Diseases, vol. 32, no. 3, pp. 419–430, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Parvizi, C. Jacovides, V. Antoci, and E. Ghanem, “Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme,” Journal of Bone and Joint Surgery A, vol. 93, no. 24, pp. 2242–2248, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. K. Hebert, R. E. Williams, R. S. Levy, and R. L. Barrack, “Cost of treating an infected total knee replacement,” Clinical Orthopaedics and Related Research, vol. 331, pp. 140–145, 1996. View at Google Scholar · View at Scopus
  22. T. P. Sculco, “The economic impact of infected total joint arthroplasty,” Instructional Course Lectures, vol. 42, pp. 349–351, 1993. View at Google Scholar · View at Scopus
  23. K. B. Kirkland, J. P. Briggs, S. L. Trivette, W. E. Wilkinson, and D. J. Sexton, “The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs,” Infection Control and Hospital Epidemiology, vol. 20, no. 11, pp. 725–730, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Rózańska, J. Wójkowska-Mach, E. Jaje, M. Bulanda, and P. B. Heczko, “Costs of surgical site infections in selected procedures in orthopedic surgery,” Chirurgia Narzadow Ruchu i Ortopedia Polska, vol. 75, no. 2, pp. 117–120, 2010. View at Google Scholar
  25. S. Bengtson, L. Borgquist, and L. Lidgren, “Cost analysis of prophylaxis with antibiotics to prevent infected knee arthroplasty,” British Medical Journal, vol. 299, no. 6701, pp. 719–720, 1989. View at Google Scholar · View at Scopus
  26. J. Ariza, G. Euba, and O. Murillo, “Infecciones relacionadas con las prótesis articulares,” Enfermedades Infecciosas y Microbiología Clínica, vol. 26, no. 6, pp. 380–390, 2008. View at Google Scholar
  27. W. Zimmerli, A. F. Widmer, M. Blatter, R. Frei, and P. E. Ochsner, “Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial,” Journal of the American Medical Association, vol. 279, no. 19, pp. 1537–1541, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Byren, P. Bejon, B. L. Atkins et al., “One hundred and twelve infected arthroplasties treated with “DAIR” (debridement, antibiotics and implant retention): antibiotic duration and outcome,” Journal of Antimicrobial Chemotherapy, vol. 63, no. 6, pp. 1264–1271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Vilchez, J. C. Martínez-Pastor, S. García-Ramiro et al., “Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement,” Clinical Microbiology and Infection, vol. 17, no. 3, pp. 439–444, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Klouche, E. Sariali, and P. Mamoudy, “Total hip arthroplasty revision due to infection: a cost analysis approach,” Orthopaedics and Traumatology, vol. 96, no. 2, pp. 124–132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Lavernia, D. J. Lee, and V. H. Hernandez, “The increasing financial burden of knee revision surgery in the United States,” Clinical Orthopaedics and Related Research, vol. 446, pp. 221–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Lange, A. Troelsen, R. W. Thomsen, and K. Søballe, “Chronic infections in hip arthroplasties: comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis,” Clinical Epidemiology, vol. 4, no. 1, pp. 57–73, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Bedair, N. Ting, K. J. Bozic, C. J. della Valle, and S. M. Sporer, “Treatment of early postoperative infections after THA: a decision analysis,” Clinical Orthopaedics and Related Research, vol. 469, no. 12, pp. 3477–3485, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Zimmerli, A. Trampuz, and P. E. Ochsner, “Current concepts: prosthetic-joint infections,” The New England Journal of Medicine, vol. 351, no. 16, pp. 1645–1654, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Jämsen, I. Stogiannidis, A. Malmivaara, J. Pajamäki, T. Puolakka, and Y. T. Konttinen, “Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach—a systematic review of the literature,” Acta Orthopaedica, vol. 80, no. 1, pp. 67–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. F. Kamath, R. C. Clement, P. B. Derman, J. P. Garino, and G. Lee, “Bipolar sealing in revision total hip arthroplasty for infection: efficacy and cost analysis,” Journal of Arthroplasty, vol. 27, no. 7, pp. 1376–1381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Hsieh, C. Tai, P. Lee, and Y. Chang, “Liquid gentamicin and vancomycin in bone cement. A potentially more cost-effective regimen,” Journal of Arthroplasty, vol. 24, no. 1, pp. 125–130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. R. M. Seldes, R. Winiarsky, L. C. Jordan et al., “Liquid gentamicin in bone cement: a laboratory study of a potentially more cost-effective cement spacer,” Journal of Bone and Joint Surgery A, vol. 87, no. 2, pp. 268–272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Haenle, C. Skripitz, W. Mittelmeier, and R. Skripitz, “Ökonomische Auswirkungeninfizierter Hüfttotalendoprothesenim DRG-System,” Der Orthopäde, vol. 41, no. 6, pp. 467–476, 2012. View at Google Scholar
  40. M. Hellmann, S. D. Mehta, D. M. Bishai, S. C. Mears, and J. M. Zenilman, “The estimated magnitude and direct cost hospital costs of prosthetic joint infections in the United States, 1997 to 2004,” Journal of Arthroplasty, vol. 35, no. 5, pp. 766.el–771.el, 2010. View at Google Scholar · View at Scopus
  41. K. J. Bozic and M. D. Ries, “The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization,” Journal of Bone and Joint Surgery A, vol. 87, no. 8, pp. 1746–1751, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. F. Widmer, “New developments in diagnosis and treatment of infection in orthopedic implants,” Clinical Infectious Diseases, vol. 33, supplement 2, pp. S94–S106, 2001. View at Google Scholar · View at Scopus
  43. B. Y. Betsch, S. Eggli, K. A. Siebenrock, M. G. Täuber, and K. Mühlemann, “Treatment of joint prosthesis infection in accordance with current recommendations improves outcome,” Clinical Infectious Diseases, vol. 46, no. 8, pp. 1221–1226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. J. Kallen, C. T. Wilson, and R. J. Larson, “Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis,” Infection Control and Hospital Epidemiology, vol. 26, no. 12, pp. 916–922, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. R. P. Evans, “Current concepts for clean air and total joint arthroplasty: laminar airflow and ultraviolet radiation: a systematic review,” Clinical Orthopaedics and Related Research, vol. 469, no. 4, pp. 945–953, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Dal-Paz, P. R. D. Oliveira, A. P. de Paula, M. C. S. da Emerick, J. R. Pécora, and A. L. L. M. Lima, “Economic impact of treatment for surgical site infections in cases of total knee arthroplasty in a tertiary public hospital in Brazil,” Brazilian Journal of Infectious Diseases, vol. 14, no. 4, pp. 356–359, 2010. View at Google Scholar · View at Scopus
  47. B. A. S. Knobben, Intra-operative bacterial contamination: control and consequences [thesis], Groningen University, Groningen, The Netherlands, 2006.
  48. J. D. Whitehouse, N. Deborah Friedman, K. B. Kirkland, W. J. Richardson, and D. J. Sexton, “The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost,” Infection Control and Hospital Epidemiology, vol. 23, no. 4, pp. 183–189, 2002. View at Google Scholar · View at Scopus